Jonathan Aschoff
Stock Analyst at Roth MKM
(0.02)
# 4,473
Out of 4,476 analysts
434
Total ratings
29.8%
Success rate
-19.9%
Average return
Main Sectors:
Stocks Rated by Jonathan Aschoff
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVCT Nuvectis Pharma | Maintained: Buy | $20 → $33 | $19.57 | +68.63% | 2 | Jul 5, 2026 | |
| GOVX GeoVax Labs | Maintained: Buy | $10 | $1.19 | +740.34% | 15 | May 26, 2026 | |
| BFRI Biofrontera | Maintained: Buy | $9 | $1.01 | +791.09% | 12 | May 15, 2026 | |
| PTHS Pelthos Therapeutics | Maintained: Buy | $55 | $25.77 | +113.43% | 5 | May 15, 2026 | |
| APVO Aptevo Therapeutics | Maintained: Buy | $21 | $4.47 | +369.80% | 10 | May 14, 2026 | |
| CLNN Clene | Maintained: Buy | $30 | $6.10 | +391.80% | 6 | May 14, 2026 | |
| REVB Revelation Biosciences | Maintained: Buy | $16 | $1.08 | +1,381.48% | 13 | May 8, 2026 | |
| MDCX Medicus Pharma | Maintained: Buy | $9 | $0.4163 | +2,061.90% | 2 | May 7, 2026 | |
| CLRB Cellectar Biosciences | Rated: Buy | $14 → $11 | $2.81 | +291.46% | 10 | May 5, 2026 | |
| CELZ Creative Medical Technology Holdings | Maintained: Buy | $20 | $1.21 | +1,552.89% | 7 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $15 | $0.40 | +3,650.00% | 10 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $3 | $0.4718 | +535.86% | 5 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $2.64 | +1,074.24% | 16 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $13.98 | +50.21% | 15 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $3 | $0.0001 | +2,999,900.00% | 8 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $2 | $0.047 | n/a | 11 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $15.46 | n/a | 7 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $3.15 | n/a | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 | $2.98 | n/a | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.06 | n/a | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.61 | $0.135 | n/a | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 | $4.46 | n/a | 9 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $36 | $44.19 | n/a | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 → $24 | $1.79 | n/a | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $620 → $500 | $0.0111 | n/a | 3 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $10.34 | n/a | 2 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.51 | n/a | 1 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $30 | $0.1831 | n/a | 3 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.36 | n/a | 5 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2.5 → $8 | $0.0001 | n/a | 5 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $0.000001 | n/a | 4 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $38 | $9.95 | n/a | 1 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $0.000001 | n/a | 3 | Nov 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 | $1.22 | n/a | 17 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $11 | $3.11 | n/a | 3 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $26 | $1.70 | n/a | 2 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.8991 | n/a | 1 | Apr 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $0.0015 | n/a | 8 | Sep 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.10 | n/a | 12 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $0.4384 | n/a | 17 | Sep 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $244.31 | n/a | 5 | Aug 19, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $92 | $116.86 | n/a | 14 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.39 | n/a | 10 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $16 | $38.37 | n/a | 11 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3 | $5.54 | n/a | 12 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $53.31 | n/a | 21 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $1.24 | n/a | 12 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $4.43 | n/a | 6 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $25.39 | n/a | 16 | Aug 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $18 | $71.04 | n/a | 13 | Aug 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.000001 | n/a | 10 | Jul 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $489 | $654.27 | n/a | 18 | Mar 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.387 | n/a | 4 | Nov 12, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $0.9504 | n/a | 3 | Dec 8, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $58.99 | n/a | 3 | Oct 24, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $555.91 | n/a | 1 | Feb 26, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 | $1.91 | n/a | 1 | Jan 17, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $27.74 | n/a | 2 | Jun 29, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $79.45 | n/a | 2 | Apr 16, 2012 |
Nuvectis Pharma
Jul 5, 2026
Maintained: Buy
Price Target: $20 → $33
Current: $19.57
Upside: +68.63%
GeoVax Labs
May 26, 2026
Maintained: Buy
Price Target: $10
Current: $1.19
Upside: +740.34%
Biofrontera
May 15, 2026
Maintained: Buy
Price Target: $9
Current: $1.01
Upside: +791.09%
Pelthos Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $55
Current: $25.77
Upside: +113.43%
Aptevo Therapeutics
May 14, 2026
Maintained: Buy
Price Target: $21
Current: $4.47
Upside: +369.80%
Clene
May 14, 2026
Maintained: Buy
Price Target: $30
Current: $6.10
Upside: +391.80%
Revelation Biosciences
May 8, 2026
Maintained: Buy
Price Target: $16
Current: $1.08
Upside: +1,381.48%
Medicus Pharma
May 7, 2026
Maintained: Buy
Price Target: $9
Current: $0.4163
Upside: +2,061.90%
Cellectar Biosciences
May 5, 2026
Rated: Buy
Price Target: $14 → $11
Current: $2.81
Upside: +291.46%
Creative Medical Technology Holdings
Apr 28, 2026
Maintained: Buy
Price Target: $20
Current: $1.21
Upside: +1,552.89%
Apr 2, 2026
Maintained: Buy
Price Target: $18 → $15
Current: $0.40
Upside: +3,650.00%
Mar 2, 2026
Maintained: Buy
Price Target: $8 → $3
Current: $0.4718
Upside: +535.86%
Feb 23, 2026
Maintained: Buy
Price Target: $31
Current: $2.64
Upside: +1,074.24%
Jul 22, 2025
Maintained: Buy
Price Target: $21
Current: $13.98
Upside: +50.21%
Jul 8, 2025
Maintained: Buy
Price Target: $4 → $3
Current: $0.0001
Upside: +2,999,900.00%
Jun 4, 2025
Maintained: Buy
Price Target: $9 → $2
Current: $0.047
Upside: n/a
May 15, 2025
Maintained: Buy
Price Target: $30
Current: $15.46
Upside: n/a
May 13, 2025
Maintained: Buy
Price Target: $13 → $11
Current: $3.15
Upside: n/a
May 12, 2025
Maintained: Buy
Price Target: €12.00
Current: $2.98
Upside: n/a
Oct 23, 2024
Downgraded: Hold
Price Target: n/a
Current: $1.06
Upside: n/a
Sep 3, 2024
Maintained: Buy
Price Target: $0.61
Current: $0.135
Upside: n/a
May 21, 2024
Rated: Buy
Price Target: $36
Current: $4.46
Upside: n/a
Mar 7, 2024
Maintained: Buy
Price Target: $25 → $36
Current: $44.19
Upside: n/a
Mar 5, 2024
Maintained: Buy
Price Target: $250 → $24
Current: $1.79
Upside: n/a
Dec 18, 2023
Maintained: Buy
Price Target: $620 → $500
Current: $0.0111
Upside: n/a
Feb 27, 2023
Maintained: Buy
Price Target: $14
Current: $10.34
Upside: n/a
Jun 15, 2022
Initiated Coverage: Buy
Price Target: $8
Current: $1.51
Upside: n/a
Apr 28, 2022
Maintained: Buy
Price Target: $4 → $30
Current: $0.1831
Upside: n/a
Oct 25, 2021
Reiterated: Buy
Price Target: $24
Current: $0.36
Upside: n/a
Sep 27, 2021
Upgraded: Buy
Price Target: $2.5 → $8
Current: $0.0001
Upside: n/a
Aug 30, 2021
Maintained: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Mar 11, 2021
Initiated Coverage: Buy
Price Target: $38
Current: $9.95
Upside: n/a
Nov 22, 2020
Maintained: Buy
Price Target: $18
Current: $0.000001
Upside: n/a
Nov 17, 2020
Downgraded: Sell
Price Target: $8
Current: $1.22
Upside: n/a
Oct 14, 2020
Reiterated: Buy
Price Target: $14 → $11
Current: $3.11
Upside: n/a
Jul 14, 2020
Maintained: Buy
Price Target: $13 → $26
Current: $1.70
Upside: n/a
Apr 20, 2020
Reiterated: Buy
Price Target: $9
Current: $0.8991
Upside: n/a
Sep 15, 2016
Reiterated: Buy
Price Target: $14
Current: $0.0015
Upside: n/a
Sep 13, 2016
Reiterated: Buy
Price Target: $4
Current: $2.10
Upside: n/a
Sep 9, 2016
Reiterated: Buy
Price Target: $55
Current: $0.4384
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: $29
Current: $244.31
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $92
Current: $116.86
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $24
Current: $0.39
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $24 → $16
Current: $38.37
Upside: n/a
Aug 9, 2016
Reiterated: Sell
Price Target: $4 → $3
Current: $5.54
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $28
Current: $53.31
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $26
Current: $1.24
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $16
Current: $4.43
Upside: n/a
Aug 5, 2016
Reiterated: Hold
Price Target: n/a
Current: $25.39
Upside: n/a
Aug 4, 2016
Reiterated: Buy
Price Target: $16 → $18
Current: $71.04
Upside: n/a
Jul 6, 2016
Reiterated: Buy
Price Target: $8
Current: $0.000001
Upside: n/a
Mar 8, 2016
Initiated Coverage: Buy
Price Target: $489
Current: $654.27
Upside: n/a
Nov 12, 2015
Reiterated: Buy
Price Target: $5
Current: $0.387
Upside: n/a
Dec 8, 2014
Maintained: Buy
Price Target: $16
Current: $0.9504
Upside: n/a
Oct 24, 2014
Maintained: Hold
Price Target: n/a
Current: $58.99
Upside: n/a
Feb 26, 2013
Downgraded: Hold
Price Target: n/a
Current: $555.91
Upside: n/a
Jan 17, 2013
Downgraded: Sell
Price Target: $1
Current: $1.91
Upside: n/a
Jun 29, 2012
Reiterated: Buy
Price Target: n/a
Current: $27.74
Upside: n/a
Apr 16, 2012
Maintained: Buy
Price Target: $13 → $11
Current: $79.45
Upside: n/a